ASTA Comments on Poppy Seed Practices and Safety
On June 16, 2025, ASTA submitted comments in response to the U.S. Food and Drug Administration's (FDA) Request for Information (RFI) on industry practices on the growing, harvesting, processing, and distribution of poppy seeds. The comments outline the typical poppy seed supply chains, as well as the role of pre- and post-harvest processing steps (e.g., microbiological treatment, baking, etc.) in reducing opiate alkaloid levels in poppy seed-based products.
06/16/2025 at 12:00 am
0
Related Resources
ASTA Comments to FDA on Sesame Allergens
ASTA issued comments to the Food and Drug Administration (FDA) in December 2018 in response to the FDA's Request for Comment on Sesame as an Allergen in Foods. The comments support labeling sesame as a major allergen, provided that sufficient time is offered to implement new labeling and GMP requirements.
ASTA Comments on FDA's Allergen Draft Guidance
ASTA submitted comments to the Food and Drug Administration(FDA) in August 2022 in response and support of the FDA's Draft Guidance for FDA Staff and Stakeholders: Evaluating the Public Health Importance of Food Allergens Other Than the Major Food Allergens Listed in the Federal Food, Drug, and Cosmetic Ac. ASTA comments note that this Draft Guidance provides a science-based framework for protecting public health with respect to allergen issues.
